Next Article in Journal
High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation
Next Article in Special Issue
Examining Safety of Biocolourants from Fungal and Plant Sources-Examples from Cortinarius and Tapinella, Salix and Tanacetum spp. and Dyed Woollen Fabrics
Previous Article in Journal
Variations in the Morphology, Mechanics and Adhesion of Persister and Resister E. coli Cells in Response to Ampicillin: AFM Study
Previous Article in Special Issue
Review on Current Status of Echinocandins Use
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Thioporidiols A and B: Two New Sulfur Compounds Discovered by Molybdenum-Catalyzed Oxidation Screening from Trichoderma polypori FKI-7382

1
Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8641, Japan
2
Graduate School of Infection Control Sciences, Kitasato University, Tokyo 108-8641, Japan
*
Authors to whom correspondence should be addressed.
Antibiotics 2020, 9(5), 236; https://doi.org/10.3390/antibiotics9050236
Submission received: 27 March 2020 / Revised: 30 April 2020 / Accepted: 2 May 2020 / Published: 7 May 2020
(This article belongs to the Special Issue Fungal Secondary Metabolites)

Abstract

:
Two new sulfur compounds, designated thioporidiol A (1) and B (2), were discovered by the MoS-screening program from a culture broth of Trichoderma polypori FKI-7382. The structures of 1 and 2 were determined as C13 lipid structures with an N-acetylcysteine moiety. The relative configuration at the C-5 and C-6 position of 1 was determined by the derivatives of α-methoxy-α-phenylacetic acid diesters, and the absolute configuration of the N-acetylcysteine moiety was determined by advanced Marfey’s analysis. Compounds 1 and 2 were evaluated for anti-microbial, cytotoxic and anti-malarial activities. Compound 2 exhibited anti-microbial activity against Candida albicans ATCC 64548.

1. Introduction

Natural products have been utilized as drugs and agricultural and chemical reagents. Newman and Cragg reported that 64% of metabolites approved as new drugs between 1981 and 2010 were directly or indirectly associated with natural products [1]. Furthermore, according to the KEGG MEDICUS (https://www.kegg.jp/kegg/medicus/) database, which presents information on commercially available medicines [2], 87% of low molecular-weight (0.1–1 kDa) medicines contain nitrogen atoms and 25% of medicines contain sulfur atoms. Therefore, searching natural resources for nitrogen- and sulfur-containing metabolites is expected to yield many unique medicines.
The search for new medicines is often focused on screening for nitrogen compounds, since the methods used to screen for nitrogen compounds are quite simple. For example, Dragendorff’s reaction can identify tertiary or quaternary amines, and compounds with odd molecular weights can be presumed to have at least one nitrogen atom (the nitrogen rule) [3,4]. However, there have been no reports about simple methods of searching for sulfur compounds. Therefore, we established MoS-screening, a method for screening of sulfur compounds using a combination of molybdenum-catalyzed oxidation and liquid chromatography-mass spectrometry (LC/MS) [5].
The MoS-screening approach allows us to identify compounds containing sulfide in its structure from microbial broths. If sulfur compounds are contained in the broths, they will be oxygenated by Mo-catalyzed oxidation. This oxidation is generally dominant over olefin epoxidation, primary alcohol and secondary alcohol oxidation. In other words, the sulfur compounds in microbial broth could be identified as sulfinyl, sulfonyl or both products, using LC/MS analysis. Then, when the original broth is compared with the oxidative broth, the oxidized peak can be easily identified. Identification of the corresponding oxidative products is relatively straightforward, because the ultraviolet (UV) spectrum is unchanged by oxidation.
In this study, to discover new sulfur compounds from microorganisms, we employed MoS-screening in combination with in-house databases and natural product databases such as the Dictionary of Natural Products (http://dnp.chemnetbase.com/). During our recent MoS-screening, a fungal metabolite with a mass-to-charge ratio (m/z) of 372.3221 [M + H]+ was deduced to be a new sulfur compound. The producing strain FKI-7382 was isolated from a sediment sample collected at Omuta city, Fukuoka Prefecture, Japan, and identified as the genus Trichoderma polypori by DNA barcoding. As a result of purification guided by LC/MS analyses from the culture broth of the fungal strain FKI-7382, a new sulfur compound, designated thioporidiol A (1), was isolated together with its analog, thioporidiol B (2). Here, we report the fermentation, isolation, structure elucidation and biological activity of 1 and 2.

2. Results and Discussion

2.1. MoS-Screening of the Culture Broth of the Fungal Strain FKI-7382

The MoS-screening program was applied to screen microbial broths for new sulfur compounds. Microbial broths were prepared in 50% aqueous ethanol and dispensed across two 96-well plates. (NH4)6Mo7O24·4H2O and 30% H2O2 were added to the wells in one plate, while, as a control, only H2O was added to the wells of the other plate. After 6 h of shaking, all of the wells were analyzed by LC/MS and the data were compared between the two plates to identify any sulfur compounds. MoS-screening of the broth cultures from 150 different fungal strains yielded a single potential sulfur compound. The candidate compound (1) was produced by the fungal strain Trichoderma polypori FKI-7382 and showed a retention time of 8.82 min and UV absorbance peaks at 232 nm (Figure 1). High resolution electrospray ionization mass spectrometry (HRESIMS) data show an [M+H]+ ion at m/z 372.1835, indicating a molecular formula of C18H29NO5S (calculated value for m/z 372.1836). The red chromatogram in Figure 1 further indicated that the candidate compound was oxygenated to a sulfonyl (7.95 min, m/z = 404.1745 [M+H]+). Comparisons of the LC/MS data and UV spectrum of the candidate compound with those of known natural products contained in the Dictionary of Natural Products database (http://dnp.chemnetbase.com/) confirmed that the candidate was a new sulfur compound.

2.2. Structure Elucidation of 1 and 2

Compound 1 was isolated as a colorless amorphous solid by silica gel and octadecylsilyl (ODS) column chromatography from a culture broth of the fungal strain FKI-7382. The 1H nuclear magnetic resonance (NMR) and heteronuclear multiple quantum correlation (HMQC) spectra in CD3OD (Table 1) indicated the six olefinic protons, two oxymethine protons, five methylene protons, a methine proton adjacent to a heteroatom, an acetyl proton and a methyl proton. The 13C NMR spectrum indicated the presence of two carbonyl carbons, six unsaturated carbons, two oxygenated carbons, three carbons seemingly adjacent to a hetero atom and two methyl carbons. The gross structure of 1 was deduced from detailed analyses of 2D NMR data, including 1H-1H correlation spectroscopy (COSY), HMQC and heteronuclear multiple bond correlation (HMBC) spectra in CD3OD (Figures S1–S6). The 1H–1H COSY spectra revealed the presence of five partial structures, ae, as shown in Figure 2A. The connectivity of partial structures a and b was determined by the HMBC cross-peaks of H-1 to C-3, H-2 to C-4, H-3 to C-1 and H-4 to C-2. The connectivity of partial structures c and d was determined by the HMBC cross-peaks of H-9 to C-11, H-10 to C-12, H-11 to C-9 and H-12 to C-10. The HMBC cross-peaks of H-6 to C-7 and H-7 to C-6 and their chemical shifts suggested the connectivity of the C-6 and C-7 constituting 1,2-diol. The partial structure e, the HMBC cross-peaks of H-1´ to C-3´, H-2´ to C-3´, and 5´-Me to C-4´ and their chemical shifts suggested an N-acetylcysteine moiety. Finally, the connectivity of C-13 and C-1´ via a sulfur atom was determined by the HMBC cross-peaks of H-13 to C-1´ and H-1´ to C-13. The geometry of three olefins was determined by detailed analysis of the homo-decoupling of 1H-NMR (Table 1) and nuclear overhauser effect (NOE). Thus, the planar structure of 1 was determined as shown in Figure 2A.
Compound 1 has three chiral carbons at C-6, C-7 and C-2´. Freire et al. reported that the absolute or relative configuration of secondary/secondary (sec,sec)-1,2-diols can be determined by comparing the NMR spectra of the resulting product of α-methoxy-α-phenylacetic acid (MPA) [6]. If the relative stereochemistry of the diol is anti, its absolute configuration can be directly determined from the differences of 1H-NMR chemical shifts between room temperature and low temperature (∆δT1T2) for substituents of the diols. Meanwhile, if the diol is syn, the assignment of its absolute configuration requires the preparation of both the bis-(R)- and bis-(S)-MPA esters, comparison of their room-temperature 1H- NMR spectra and calculation of the ∆δRS signs for the methines of the α-protons of the diols.
The preparation of the MPA diester of 1 is described below. To protect C-2´ carboxylic acid, compound 1 was derivatized by TMS-diazomethane to methyl ester 3 (Figure 3). The sec,sec-1,2-diols at C-6 and C-7 of 3 were derivatized to (R)-MPA diester 4. After separation of the crude product by preparative thin layer chromatography (TLC), final purification was conducted by preparative high-performance liquid chromatography (HPLC) to afford 4. Compound 4 was assigned by 1D and 2D NMR data. 1H NMR data measured in 213K and analysis of ∆δT1T2 values confirmed the anti-stereochemistry for C-6 and C-7 (Figure 3, Figures S13 and S14). Finally, to determine the absolute configuration of the N-acetylcysteine moiety, 1 was defined by advanced Marfey’s analysis of the hydrolysate of 1 after desulfurization with Raney nickel as a catalyst [7,8]. After treatment of 1 with Raney nickel for desulfurization, the product was hydrolyzed by 6 M HCl. The advanced Marfey’s procedure of the hydrolysate led to identification of the stereochemistry of the alanine as the L-alanine (Figure 4).
Compound 2 was isolated as a colorless amorphous solid and determined to have the molecular formula C18H29NO5S by HRESIMS (m/z 372.1837 [M+H]+, calculated for 372.1836). The 1H NMR, 13C NMR and UV spectra were similar to that of 1. These results suggested that 2 is an analog of 1. The gross structure of 2 was deduced from detailed analyses of 2D NMR data, including 1H-1H COSY, HMQC and HMBC spectra in CD3OD (Figure 2B, Figures S6–S12). These results suggested that 2 is an enantiomer of 1. Unfortunately, the stereochemistry of compound 2 cannot be determined at C-6, C-7 and the N-acetylcysteine moiety due to low yield.
Compound 1 and 2 were evaluated for several biological activities, including anti-cancer, anti-microbial and anti-malarial activities. As a result of these assays, 1 showed no activity. However, 2 showed anti-microbial activity against Candida albicans ATCC 64548, that is a sensitive stain for fluconazole [9]. When the strain ATCC 64548 was treated with 30 µg of 2 on a 6 mm paper disc, an 8 mm inhibition zone was produced. These results suggested that the stereochemistry is important for anti-microbial activity against C. albicans ATCC 64548.

3. Materials and Methods

3.1. General Experimental Procedures

Silica gel and octa-decanoyl-silicon (ODS) were purchased from Fuji Silysia Chemical (Aichi, Japan). All solvents were purchased from Kanto Chemical (Tokyo).
High-resolution electrospray ionization (HRESI)-MS spectra were measured using an AB Sciex TripleTOF 5600+ System (AB Sciex, Framingham, MA, USA). Nuclear magnetic resonance (NMR) spectra were measured using a JEOL JNM-ECA 500 spectrometer (JEOL, Tokyo), with 1H-NMR at 500 MHz and 13C NMR at 100 MHz in methanol-d4 (CD3OD) and chloroform-d (CDCl3). The chemical shifts are expressed in parts per million (ppm) and are referenced to residual CHD2OD (3.31 ppm) and CHCl3 (7.26 ppm) in the 1H-NMR spectra and CD3OD (49.0 ppm) and CDCl3 (77.0 ppm) in the 13C-NMR spectra. UV spectra were measured with a Hitachi U-2810 spectrophotometer (Hitachi, Tokyo). Infrared radiation (IR) spectra (KBr) were taken on a JASCO FT/IR-4600 Fourier Transform Infrared Spectrometer (JASCO, Tokyo). Optical rotations were measured on a JASCO model DIP-1000 polarimeter (JASCO, Tokyo).

3.2. Fermentation of Strain FKI-7382 and Isolation of 1 and 2

Strain FKI-7382 was grown on a modified Miura’s medium (LcA: consisting of 0.1% glycerol, 0.08% KH2PO4, 0.02% K2HPO4, 0.02% MgSO4·7H2O, 0.02% KCl, 0.2% NaNO3, 0.02% yeast extract and 1.5% agar (adjusted to pH 6.0 before sterilization)) slant. A loop of spores of the strain was inoculated into five 500 mL Erlenmeyer flasks containing 100 mL seed medium consisting of 2% glucose, 0.2% yeast extract, 0.5% hipolypeptone, 0.1% KH2PO4, 0.05% MgSO4·7H2O and 0.1% agar, which was shaken at 210 rpm on a rotary shaker at 27 °C for 3 days. Twenty bags, each containing 500 g of rice (Hanamasa, Tokyo), 5 g of seaweed tea (ITO EN, Tokyo) and 200 mL of tap water were sterilized, and then a 25 mL aliquot of the seed culture was added to each. The bags were allowed to ferment for 13 days at 25 °C. The total volume of cultured rice (10 kg) was extracted with 10 L of MeOH and centrifuged to separate the cells and supernatant.
The MeOH in supernatant (10 L) was concentrated in vacuo and the suspension was separated by ODS (Chromatorex ODS-DM1020MT) (ϕ100 × 300 mm) middle phase liquid chromatography (MPLC) with a stepwise elution system (0%, 20%, 40%, 60%, 80% and 100% MeOHaq containing 0.1% formic acid; flow rate of 40 mL/min). The 80% MeOH fraction containing 1 was separated by silica gel flash column chromatography (ϕ25 x 150 mm) with a stepwise elution system (CHCl3:MeOH = 50:1, 25:1, 12:1, 6:1, 3:1, 0:1; flow rate of 20 mL/min). The eluates were collected in eight-fractions by guiding UV detection of 254 nm. The seventh fraction contained 1 and its analog, thioporidiol B (2). This fraction (59.3 mg) was purified by reversed-phase preparative HPLC (CAPCELL PAK C18 MG-III column, ϕ20 × 250 mm; OSAKA SODA, Osaka, Japan) using a solvent system of 65% MeOHaq containing 0.1% formic acid to yield 1 (15.4 mg) and 2 (6.3 mg).
Thioporidiol A (1): pale yellow amorphous solid; [α]D23 = −14.5 (c = 0.1, MeOH); IR (KBr) νmax cm−1 3381, 1728, 1623; UV (CH3OH) λmax (log ε) 233 (4.26).
Thioporidiol B (2): pale yellow amorphous solid; [α]D25 = −29.1 (c = 0.1, CH3OH); IR (KBr) νmax cm−1 3376, 1729, 1302, 1232; UV (CH3OH) λmax (log ε) 232 (4.22). The 1H- and 13C-NMR data in CD3OD are shown in Table 1.

3.3. Preparation of MPA Diester of 1

To protect C-2´ carboxylic acid, compound 1 (7.0 mg) dissoleved in a 1:1 mixture (600 μL) of benzen and methaol was treated with TMS-diazomethane (100 μL) (Tokyo Chemical Indastry, Tokyo, Japan). After stirring for 2 hours at room temperature, the solution was evaporated to yield a C-2´ methyl ester analog 3 (7.0 mg). A small amount of 3 (6.0 mg) dissolved in a 1:1 mixture (200 μL) of dry pyridine and methylene chloride was treated with (R)-MPA (26.0 mg) (Tokyo Chemical Indastry), 4-dimethylaminopyridine (20.0 mg) (Tokyo Chemical Indastry) and N, N´-dicyclohexylcarbodiimide (32.0 mg) (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan). After stirring overnight at room temperature, the product was purified by preparative TLC (CHCl3:MeOH = 9:1) to yield the crude MPA diester of 1 (Rf value 0.70). Further purification by preparative HPLC (CAPCELL PAK C18 MG-III column, ϕ20 × 250 mm; OSAKA SODA, Osaka, Japan) using a solvent system of 80% MeOHaq containing 0.1% formic acid, afforded to pure MPA diester 4 (1.5 mg).

3.4. Absolute Configuration of the N-Acetylcysteine Moiety of 1

Advanced Marfey’s analyses for acid hydrolysis of a de-sulfurized 1 with Raney nickel were used to determine the absolute configurations of the N-acetylcysteine moiety of both. To a stirred solution of 1 (1.1 mg, 2.96 µmol) in MeOH (1.0 mL), Raney Ni (17.9 mg) was added at room temperature. The suspension was then purged with an H2 atmosphere under 1 atm. After stirring for 21 h at room temperature, the suspension was filtered through a filter pad and washed with MeOH (1.0 mL × 3) and H2O (1.0 mL × 3). MeOH and H2O filtrates were concentrated in vacuo. To hydrolyze the acetyl moiety of N-acetylcysteine, the H2O filtrate, processed as above, was dissolved in 500 μL of 6 M hydrochloric acid (HCl), followed by heat treatment at 100 °C for 12 h. The product was concentrated to dryness in vacuo and the residue was dissolved in 500 μL of H2O. Twenty microliters of 1 M NaHCO3 and 50 μL of Nα-(5-fluoro-2,4-dinitrophenyl)-D-leucinamide (D-FDLA) were added to the 50 μL of hydrolysates, followed by incubation at 37 °C for 1 h. The mixtures were neutralized by addition of 20 μL of 1 M HCl and then concentrated to dryness in vacuo. The resultant dried residue was dissolved in 1 mL acetonitrile, followed by passage through a filter. Similarly, the standard L- and D-alanine were derivatized according to the method described above. The D-FDLA derivatives of the hydrolysate and the standard amino acids were subjected to LC/MS analysis at 40 °C using the following gradient program: solvent A, H2O with 0.1% formic acid; solvent B, MeOH with 0.1% formic acid; linear gradient 5–100% of B from 2 to 10 min.

3.5. Anti-Microbial Activity of 1 and 2

The antimicrobial activities of 1 and 2 against six microorganisms, Bacillus subtilis ATCC6633, Kocuria rhizophila ATCC9341, Staphylococcus aureus ATCC6538P, Escherichia coli NIHJ, Xanthomonas oryzae pv. oryzae KB88 and Candida albicans ATCC 64548, were evaluated using the paper disc method. Agar plates were spread with the six strains, and then paper discs including 1 and 2 (final concentration: 1, 3, 10, 30 µg/disc) were placed. All microorganisms, except X. oryzae, were incubated at 37 °C. X. oryzae was incubated at 27 °C for 48 h. After incubation, the inhibition zones were measured.

4. Conclusions

This study describes new sulfur compounds containing an N-acetylcysteine moiety, thioporidiol A (1) and B (2), produced by the fungal strain Trichoderma polypori FKI-7382. To the best of our knowledge, this is the first report describing a natural product containing an N-acetylcysteine moiety from fungal metabolites. For example, in the case of nanaomycin H, it is known that an N-acetylcysteine moiety is introduced to secondary metabolites as a part of mycothiol [10]. Mycothiol, which is comprised of N-acetylcysteine amide-linked to α-glucosamine and myo-inositol moieties, is a thiol metabolite that is produced in most actinobacteria and plays a role in protecting against the oxygen toxicity of glutathione in eukaryotes [11]. However, the role and derivation of N-acetylcysteine in fungi is still unclear. It is expected that these relationships will be unveiled in the future. The biosynthesis of mycothiol in actinobacteria is accomplished in five steps by several of the enzymes catalyzing the reactions, and the structure is 1-O-[2-[[(2R)-2-(acetylamino)-3-mercapto-1-oxopropyl]amino]-2-deoxy-α-D-glucopyranosyl]-D-myo-inositol [12]. The absolute configuration of N-acetylcysteine moiety is the same one as in actinobacteria.

Supplementary Materials

The following are available online at https://www.mdpi.com/2079-6382/9/5/236/s1, The 1D and 2D NMR data of 1 and 2 are shown in Figures S1–S12. 1H-NMR data of 4 measured in 25 °C and −30 °C are shown in Figures S13 and S14.

Author Contributions

H.M. performed the fermentation, isolation and structural elucidation and wrote this manuscript. R.M. cultured the screening samples including the strain FKI-7382. M.H. and K.N. isolated and identified the fungal strain FKI-7382. Y.N. and T.S. performed the Raney-Nickel reaction. Y.T., S.Ō. and T.N. supervised this study. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by a Sasakawa Scientific Research Grant from the Japan Science Society to H. Matsuo (2019-3025), a JSPS KAKENHI for Young Scientists (grant no. JP19K15758) to H. Matsuo, and a Kitasato University Research Grant for Young Researchers, awarded to H. Matsuo.

Acknowledgments

This study was supported by the Institute for Fermentation, Osaka, Japan. We thank Noriko Sato (School of Pharmacy, Kitasato University) for the measurements of NMR.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016, 7, 629–661. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38, D355–D360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Ōmura, S.; Tanaka, H.; Awaya, J.; Narimatsu, Y.; Konda, Y.; Hata, T. Pyrindicin, a New Alkaloid from a Streptomyces Strain Taxonomy, Fermentation, Isolation and Biological Activity. Agric. Biol. Chem. 1974, 38, 899–906. [Google Scholar]
  4. Miyano, R.; Matsuo, H.; Mokudai, T.; Noguchi, Y.; Higo, M.; Nonaka, K.; Niwano, Y.; Sunazuka, T.; Shiomi, K.; Takahashi, Y.; et al. Trichothioneic acid, a new antioxidant compound produced by the fungal strain Trichoderma virens FKI-7573. J. Biosci. Bioeng. 2020. in Press. [Google Scholar] [CrossRef] [PubMed]
  5. Matsuo, H.; Hanamure, Y.; Miyano, R.; Takahashi, Y.; Omura, S.; Nakashima, T. Screening for Sulfur Compounds by Molybdenum-Catalyzed Oxidation Combined with Liquid Chromatography-Mass Spectrometry. Molecules 2020, 25, 240. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Freire, F.; Calderon, F.; Seco, J.M.; Fernandez-Mayoralas, A.; Quinoa, E.; Riguera, R. Relative and absolute stereochemistry of secondary/secondary diols: Low-temperature 1H NMR of their bis-MPA esters. J. Org. Chem. 2007, 72, 2297–2301. [Google Scholar] [CrossRef] [PubMed]
  7. Mozingo, R.; Wolf, D.E.; Harris, S.A.; Folkers, K. Hydrogenolysis of Sulfur Compounds by Raney Nickel Catalyst. J. Am. Chem. Soc. 1943, 65, 1013–1016. [Google Scholar] [CrossRef]
  8. Marfey, P. Determination of D-amino acids. II. Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg Res. Commun. 1984, 49, 591–596. [Google Scholar] [CrossRef] [Green Version]
  9. Espinel-Ingroff, A.; Rodríguez-Tudela, J.L.; Martínez-Suárez, J.V. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 1995, 33, 3154–3158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Nakashima, T.; Kimura, T.; Miyano, R.; Matsuo, H.; Hirose, T.; Kimishima, A.; Nonaka, K.; Iwatsuki, M.; Nakanishi, J.; Takahashi, Y.; et al. Nanaomycin H: A new nanaomycin analog. J. Biosci. Bioeng. 2017, 123, 765–770. [Google Scholar] [CrossRef] [PubMed]
  11. Newton, G.L.; Bewley, C.A.; Dwyer, T.J.; Horn, R.; Aharonowitz, Y.; Cohen, G.; Davies, J.; Faulkner, D.J.; Fahey, R.C. The structure of U17 isolated from Streptomyces clavuligerus and its properties as an antioxidant thiol. Eur. J. Biochem. 1995, 230, 821–825. [Google Scholar] [CrossRef] [PubMed]
  12. Gerald, L.N.; Nancy, B.; Robert, C.F. Biosynthesis and functions of mycothiol, the unique protective thiol of actinobacteria. Microbiol. Mol. Biol. Rev. 2008, 72, 471–494. [Google Scholar]
Figure 1. Comparison of total wavelength chromatograms (TWCs) obtained from liquid chromatography-mass spectrometry (LC/MS) analysis of the oxidized and non-oxidized culture broth of the strain FKI-7382.
Figure 1. Comparison of total wavelength chromatograms (TWCs) obtained from liquid chromatography-mass spectrometry (LC/MS) analysis of the oxidized and non-oxidized culture broth of the strain FKI-7382.
Antibiotics 09 00236 g001
Figure 2. 2D NMR correlations of 1 (A) and 2 (B).
Figure 2. 2D NMR correlations of 1 (A) and 2 (B).
Antibiotics 09 00236 g002
Figure 3. (A) The structure of methylated 1, (B) Δδ values (Δδ in ppm) = ΔδT1T2) obtained for (R)-MPA diester (4).
Figure 3. (A) The structure of methylated 1, (B) Δδ values (Δδ in ppm) = ΔδT1T2) obtained for (R)-MPA diester (4).
Antibiotics 09 00236 g003
Figure 4. Determination of absolute configuration of the N-acetylcysteine moiety derived from 1 by the advanced Marfey’s method. The data are shown as XIC of +TOF MS for m/z = 384 to 385.
Figure 4. Determination of absolute configuration of the N-acetylcysteine moiety derived from 1 by the advanced Marfey’s method. The data are shown as XIC of +TOF MS for m/z = 384 to 385.
Antibiotics 09 00236 g004
Table 1. 1H and 13C NMR chemical shifts of 1 and 2.
Table 1. 1H and 13C NMR chemical shifts of 1 and 2.
Thioporidiol A (1)Thioporidiol B (2)
PositionδHδCδHδC
11.63 (dd, 3.5, 1.5, 3H)18.1 1.63 (dd, 4.0, 1.0, 3H)18.1
25.46 (dd, J = 14.0, 3.5 Hz, 1H)126.0 5.45 (dd, J = 14.0, 4.0 Hz, 1H)126.1
35.45 (dddd, J = 14.0, 5.0, 5.0, 1.5 Hz, 1H)132.3 5.45 (dddd, J = 14.0, 5.0, 3.0, 1.5 Hz, 1H)131.1
42.03 (dddd, J = 14.0, 10.0, 9.0, 5.0 Hz, 1H)29.9 2.03 (dddd, J = 14.0, 8.0, 8.0, 5.0 Hz, 1H)30.0
2.20 (dddd, J = 14.0, 10.0, 5.0, 5.0 Hz, 1H) 2.15 (dddd, J = 14.0, 9.0, 6.0, 3.0 Hz, 1H)
51.41 (dddd, J = 14.0, 9.0, 9.0, 5.0 Hz, 1H)33.6 1.49 (dddd, J = 14.0, 8.0, 8.0, 6.0 Hz, 1H)33.9
1.68 (dddd, J = 14.0, 10.0, 7.0, 3.0 Hz, 1H) 1.56 (dddd, J = 14.0, 9.0, 8.0, 4.0 Hz, 1H)
63.38 (ddd, J = 9.0, 6.0, 3.0 Hz, 1H)74.8 3.41 (ddd, J = 8.0, 4.0, 4.0 Hz, 1H)73.9
73.40 (ddd, J = 8.0, 6.0, 3.5 Hz, 1H)75.8 3.45 (ddd, J = 8.0, 4.5, 4.0 Hz, 1H)75.0
82.19 (ddd, J = 14.5, 8.0, 7.0 Hz, 1H)37.3 2.23 (ddd, J = 14.0, 8.0, 7.0 Hz, 1H)37.5
2.42 (ddd, J = 14.5, 7.0, 3.5 Hz, 1H) 2.34 (ddd, J = 14.0, 7.0, 4.5 Hz, 1H)
95.77 (ddd, J = 14.0, 7.0, 7.0 Hz, 1H)132.3 5.74 (ddd, J = 14.0, 7.0, 7.0 Hz, 1H)132.2
106.12 (d, J = 14.0, 11.0 Hz, 1H)132.8 6.13 (d, J = 14.0, 10.0 Hz, 1H)132.8
116.16 (d, J = 14.0, 11.0 Hz, 1H)134.7 6.17 (d, J = 14.0, 10.0 Hz, 1H)134.6
125.53 (ddd, J = 14.0, 7.5, 7.0 Hz, 1H)128.0 5.54 (ddd, J = 14.0, 7.5, 7.0 Hz, 1H)128.1
133.19 (dd, J = 14.0, 7.0 Hz, 1H)34.8 3.19 (dd, J = 14.5, 7.0 Hz, 1H)34.8
3.21 (dd, J = 14.0, 7.5 Hz, 1H) 3.21 (dd, J = 14.5, 7.5 Hz, 1H)
173.9 173.8
4.57 (dd, J = 8.0, 5.0 Hz, 1H)53.4 4.57 (dd, J = 8.0, 5.0 Hz, 1H)53.3
2.74 (dd, J = 14.0, 8.0 Hz, 1H)33.0 2.74 (dd, J = 14.0, 8.0 Hz, 1H)33.0
2.95 (dd, J = 14.0, 5.0 Hz, 1H) 2.95 (dd, J = 14.0, 5.0 Hz, 1H)
173.3 173.3
2.00 (s, 3H)22.4 2.00 (s, 3H)22.4

Share and Cite

MDPI and ACS Style

Matsuo, H.; Noguchi, Y.; Miyano, R.; Higo, M.; Nonaka, K.; Sunazuka, T.; Takahashi, Y.; Ōmura, S.; Nakashima, T. Thioporidiols A and B: Two New Sulfur Compounds Discovered by Molybdenum-Catalyzed Oxidation Screening from Trichoderma polypori FKI-7382. Antibiotics 2020, 9, 236. https://doi.org/10.3390/antibiotics9050236

AMA Style

Matsuo H, Noguchi Y, Miyano R, Higo M, Nonaka K, Sunazuka T, Takahashi Y, Ōmura S, Nakashima T. Thioporidiols A and B: Two New Sulfur Compounds Discovered by Molybdenum-Catalyzed Oxidation Screening from Trichoderma polypori FKI-7382. Antibiotics. 2020; 9(5):236. https://doi.org/10.3390/antibiotics9050236

Chicago/Turabian Style

Matsuo, Hirotaka, Yoshihiko Noguchi, Rei Miyano, Mayuka Higo, Kenichi Nonaka, Toshiaki Sunazuka, Yōko Takahashi, Satoshi Ōmura, and Takuji Nakashima. 2020. "Thioporidiols A and B: Two New Sulfur Compounds Discovered by Molybdenum-Catalyzed Oxidation Screening from Trichoderma polypori FKI-7382" Antibiotics 9, no. 5: 236. https://doi.org/10.3390/antibiotics9050236

APA Style

Matsuo, H., Noguchi, Y., Miyano, R., Higo, M., Nonaka, K., Sunazuka, T., Takahashi, Y., Ōmura, S., & Nakashima, T. (2020). Thioporidiols A and B: Two New Sulfur Compounds Discovered by Molybdenum-Catalyzed Oxidation Screening from Trichoderma polypori FKI-7382. Antibiotics, 9(5), 236. https://doi.org/10.3390/antibiotics9050236

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop